NCT01679834View on ClinicalTrials.gov

An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

7,500

Participants

Timeline

Start Date

November 24, 2014

Primary Completion Date

July 14, 2017

Study Completion Date

July 14, 2017

Conditions
Hepatitis C, Chronic
Trial Locations (2)

30625

Hanover

44623

Herne

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01679834 - An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter